News

January 9th, 2023 / Event

Biotech Showcase: The Investor Conference for Innovators (San Francisco)

November 7th, 2022 / News

Ubiquigent appoints Dr Hozefa Amijee as Head of Business Development

November 6th, 2022 / Event

Targeted Protein Degradation and Ubiquitin Biology (Vancouver)

October 31st, 2022 / News

Ubiquigent obtains exclusive license for UbiSite® technology to strengthen its specialist drug discovery services

October 24th, 2022 / News

Ubiquigent Appoints Dr Sheelagh Frame, CSO, to its Board of Directors

October 24th, 2022 / Event

BIO-Europe (Leipzig)